Hepatic Artery Infusion of Floxuridine in Combination With Systemic Chemotherapy for Pancreatic Cancer Liver Metastasis: A Propensity Score-Matched Analysis in Two Centers
AimTo evaluate the efficacy of hepatic artery infusion (HAI) of floxuridine (FUDR) in combination with systemic chemotherapy in patients with pancreatic cancer liver metastases (PCLM).Patients and MethodsWe retrospectively collected clinical data of 347 patients with PCLM who underwent first-line ch...
Main Authors: | Changli Peng, Bin Xu, Juxiong Xiao, Chunhui Zhou, Xiaodong Li, Hongbing Shi, Weiguang Qiang, Tianming Wang, Jiemin Zhao, Fei Liu, Gang Li, Haiping Li, Changyong Chen, Liangrong Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.652426/full |
Similar Items
-
Genomic stratification beyond Ras/B‐Raf in colorectal liver metastasis patients treated with hepatic arterial infusion
by: J. Joshua Smith, et al.
Published: (2019-11-01) -
The Dipeptide Monoester Prodrugs of Floxuridine and Gemcitabine—Feasibility of Orally Administrable Nucleoside Analogs
by: Yasuhiro Tsume, et al.
Published: (2014-01-01) -
Supramolecular Amphiphiles Based on Pillar[5]arene and Meroterpenoids: Synthesis, Self-Association and Interaction with Floxuridine
by: Alan A. Akhmedov, et al.
Published: (2021-07-01) -
Transcriptome profiling identifies genes and pathways deregulated upon floxuridine treatment in colorectal cancer cells harboring GOF mutant p53
by: Arindam Datta, et al.
Published: (2016-06-01) -
Enhanced Absorption and Growth Inhibition with Amino Acid Monoester Prodrugs of Floxuridine by Targeting hPEPT1 Transporters
by: Gordon L. Amidon, et al.
Published: (2008-06-01)